{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:36Z","timestamp":1787071116827,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sublingual (SL) buprenorphine has been used as a modality of managing acute postoperative pain in many studies. This systematic review aimed to investigate the safety and efficacy of SL buprenorphine as an analgesic for various surgeries. After registering the protocol with PROSPERO, we searched PubMed, Cochrane Library, and Ovid databases with relevant keywords. The primary outcomes were 24-hour pain scores, and the secondary outcomes were postoperative nausea and vomiting, sedation scores, pruritus, rescue analgesia, and urinary retention. The risk of bias scale was used to identify the quality of evidence. From the 103 articles identified, four randomized-controlled trials fulfilled the inclusion criteria for qualitative analysis. The overall risk of bias was low. Most of the studies showed that the use of SL buprenorphine led to either better or comparable pain scores when compared to a control group with lesser or tolerable adverse events. There was a lot of heterogeneity across the studies in this systematic review in terms of the type of surgery performed, the comparison groups, doses of buprenorphine, and the outcomes that were assessed. Therefore, a quantitative meta-analysis was not performed. The results of this systematic review should be interpreted with caution due to heterogeneity in the methodology. Adequately powered studies with robust methodology should investigate the safety and efficacy of SL buprenorphine when used for postoperative analgesia.<\/jats:p>","DOI":"10.4103\/joacp.joacp_245_23","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T21:00:32Z","timestamp":1721422832000},"page":"574-581","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of sublingual buprenorphine in managing acute postoperative pain \u2013 A systematic review"],"prefix":"10.4103","volume":"40","author":[{"given":"Abhijit S.","family":"Nair","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Ibra Hospital, Ministry of Health-Oman, Ibra, Sultanate of Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujjwalraj","family":"Dudhedia","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Dr. L.H. Hiranandani Hospital, Powai, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad Vilas","family":"Bodas","sequence":"additional","affiliation":[{"name":"Krishna Institute of Medical Sciences (Deemed to be University), Malkapur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Rangaiah","sequence":"additional","affiliation":[{"name":"Department of Anaesthetics and Pain Management, Walsall Manor Hospital, Moat Rd, Walsall WS2 9PS, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitinkumar","family":"Borkar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Surgery, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"R1-20241202","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","article-title":"Transition from acute to chronic pain after surgery","volume":"393","author":"Glare","year":"2019","journal-title":"Lancet"},{"key":"R2-20241202","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11916-018-0690-8","article-title":"New Advances in acute postoperative pain management","volume":"22","author":"Mitra","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"R4-20241202","doi-asserted-by":"crossref","first-page":"37517","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations:A comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol Res"},{"key":"R5-20241202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1865-1380-7-1","article-title":"Sublingual buprenorphine for acute renal colic pain management:A double-blind, randomized controlled trial","volume":"7","author":"Payandemehr","year":"2014","journal-title":"Int J Emerg Med"},{"key":"R6-20241202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40122-017-0082-5","article-title":"Sublingual buprenorphine efficacy in renal colic pain relief:A randomized placebo-controlled clinical trial","volume":"6","author":"Mozafari","year":"2017","journal-title":"Pain Ther"},{"key":"R7-20241202","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.4081\/ejtm.2019.8098","article-title":"Comparison of sublingual buprenorphine and intravenous morphine in reducing bone metastases associated pain in cancer patients","volume":"29","author":"Jamalian","year":"2019","journal-title":"Eur J Transl Myol"},{"key":"R8-20241202","first-page":"60","article-title":"Post-operative analgesia in opioid dependent patients:Comparison of intravenous morphine and sublingual buprenorphine","volume":"7","author":"Alizadeh","year":"2015","journal-title":"Addict Health"},{"key":"R9-20241202","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.4103\/ija.IJA_361_19","article-title":"Feasibility and efficacy of sublingual buprenorphine tablets in managing acute postoperative pain after elective breast cancer surgeries:A series of 10 cases","volume":"63","author":"Sumanth","year":"2019","journal-title":"Indian J Anaesth"},{"key":"R10-20241202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R11-20241202","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2:A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R12-20241202","first-page":"280","article-title":"Comparison of intravenous morphine with sublingual buprenorphine in management of postoperative pain after closed reduction orthopedic surgery","volume":"3","author":"Soltani","year":"2015","journal-title":"Arch Bone Jt Surg"},{"key":"R13-20241202","doi-asserted-by":"crossref","first-page":"e113909","DOI":"10.5812\/aapm.113909","article-title":"Effectiveness of sublingual buprenorphine and fentanyl pump in controlling pain after open cholecystectomy","volume":"11","author":"Norozi","year":"2021","journal-title":"Anesth Pain Med"},{"key":"R14-20241202","first-page":"102347","article-title":"The effect of preoperative sublingual buprenorphine on postoperative pain after lumbar discectomy:A randomized controlled trial","volume":"65","author":"Kiabi","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"R15-20241202","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/2045-9912.345170","article-title":"A randomized controlled study to compare analgesic efficacy of sublingual buprenorphine and intravenous tramadol in patients undergoing mastectomy","volume":"13","author":"Dokku","year":"2023","journal-title":"Med Gas Res"},{"key":"R16-20241202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12871-021-01531-2","article-title":"Complete opioid transition to sublingual Buprenorphine after abdominal surgery is associated with significant reductions in opioid requirements, but not reduction in hospital length of stay:A retrospective cohort study","volume":"22","author":"Heldreich","year":"2022","journal-title":"BMC Anesthesiol"},{"key":"R17-20241202","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1213\/ANE.0000000000004673","article-title":"Efficacy and safety of magnesium for the management of chronic pain in adults:A systematic review","volume":"131","author":"Park","year":"2020","journal-title":"Anesth Analg"},{"key":"R18-20241202","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews:Reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"R19-20241202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0019-5049.65359","article-title":"A comparative study of intrathecal and epidural buprenorphine using combined spinal-epidural technique for caesarean section","volume":"54","author":"Ipe","year":"2010","journal-title":"Indian J Anaesth"},{"key":"R20-20241202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bjan.2020.04.004","article-title":"Transdermal buprenorphine for acute postoperative pain:A systematic review","volume":"70","author":"Machado","year":"2020","journal-title":"Braz J Anesthesiol"},{"key":"R21-20241202","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2147\/JPR.S305146","article-title":"Benefit-risk analysis of buprenorphine for pain management","volume":"14","author":"Hale","year":"2021","journal-title":"J Pain Res"},{"key":"R22-20241202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/sja.sja_822_22","article-title":"Buprenorphine for acute post-surgical pain:A systematic review and meta-analysis","volume":"17","author":"Albaqami","year":"2023","journal-title":"Saudi J Anaesth"},{"key":"R23-20241202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jpainsymman.2010.01.013","article-title":"A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain","volume":"40","author":"James","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"R24-20241202","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bja.2017.11.086","article-title":"Efficacy and adverse effects of buprenorphine in acute pain management:Systematic review and meta-analysis of randomised controlled trials","volume":"120","author":"White","year":"2018","journal-title":"Br J Anaesth"},{"key":"R25-20241202","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4103\/IJPC.IJPC_41_19","article-title":"Sublingual buprenorphine:A feasible alternative for treating breakthrough chronic pain","volume":"25","author":"Nair","year":"2019","journal-title":"Indian J Palliat Care"},{"key":"R26-20241202","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine treatment for opioid use disorder:An overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"key":"R27-20241202","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/ajh.26699","article-title":"Converting adults with sickle cell disease from full agonist opioids to buprenorphine:A reliable method with safety and early evidence of reduced acute care utilization","volume":"97","author":"David","year":"2022","journal-title":"Am J Hematol"},{"key":"R28-20241202","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.annemergmed.2011.10.021","article-title":"Sublingual buprenorphine in acute pain management:A double-blind randomized clinical trial","volume":"59","author":"Jalili","year":"2012","journal-title":"Ann Emerg Med"}],"container-title":["Journal of Anaesthesiology Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.joacp_245_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:44Z","timestamp":1787067704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joacp.joacp_245_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/joacp.joacp_245_23","relation":{},"ISSN":["0970-9185","2231-2730"],"issn-type":[{"value":"0970-9185","type":"print"},{"value":"2231-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"2023-06-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}